BIO Embraces New Strategic Direction for Future Beyond Pandemic Washington, DC –  The Biotechnology Innovation Organization (BIO), which announced its transition to a new CEO in June to Dr. Michelle McMurry-Heath, is announcing a new leadership team and organizational structure that promises to provide long-term stability for the organization’s ambitious agenda. Some staff reductions were made…

Read More

How Atlanta’s history of public health leadership put the city on the front lines of COVID-19 vaccine research The eyes of the nation have been on Atlanta since before COVID-19 even made its way into the United States.  The Centers of Disease Control and Prevention (CDC) began monitoring the virus in January and with the race to…

Read More

U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus. Thursday’s approval of the two-shot combo called Cabenuva is expected to make it easier for people to stay on track with their HIV medicines and to do…

Read More

The Covid-19 vaccine from Pfizer-BioNTech appears to work just as well against a fast-spreading variant of the coronavirus first identified in the United Kingdom as it does against earlier forms of the pathogen, the companies reported in a study Wednesday. The paper from company scientists, which has not yet been peer-reviewed, is a welcome signal that existing…

Read More

Vero Biotech LLC, an Atlanta, Georgia-based biotechnology company, closed a senior secured term loan of $50m. Runway Growth Capital provided the financing. Led by Brent V. Furse, CEO and President, Vero Biotech (formerly known as GeNO LLC) is a biotechnology company focused on the design, development, and commercialization of next-generation products to meet the needs of patients with…

Read More

Dr. David Kessler, who helped speed the development and approval of AIDS drugs in the 1990s, will become the top science official at Operation Warp Speed. President-elect Joseph R. Biden Jr. has chosen Dr. David Kessler to help lead Operation Warp Speed, the program to accelerate development of Covid-19 vaccines and treatments, according to transition officials. Dr.…

Read More

WASHINGTON — President-elect Biden called on Congress to approve $415 billion in emergency spending to scale up vaccinations, testing, contact tracing, genomic sequencing, and other efforts to fight Covid-19 — a major part of a broader, $1.9 trillion stimulus proposal. The massive plan, outlined in an address Thursday evening, would allocate $20 billion for a…

Read More

Atlanta-based health technology startup OncoLens raised a $7.25 million Series A round to increase its platform and hire more employees.   Atlanta’s BIP Capital, Martin Ventures and SeedToB participated in the round, according to a press release. The Series A brings the startup’s total investments to $8 million.   CEO and co-founder Anju Mathew said the new capital will fuel the company’s rapid growth in the cancer treatment space. OncoLens provides a care treatment…

Read More

ATLANTA – Emory University’s infectious diseases program ranks 5th in the United States and 9th in the world, according to a new listing from U.S. News & World Report. “Emory is a global leader when it comes to the research and treatment of infectious diseases,” says Jonathan S. Lewin, executive vice president for health affairs…

Read More